The Human Is Part of the Treatment
While listening to the FDA’s public hearing on the possible future therapeutic use of psychedelic drugs, I expected to hear mainly about molecules, dosage, purity, clinical endpoints and adverse events. Those questions were certainly present. But the conversation kept returning to a person. The person who prepares the patient, remains in the room while ordinary […]
The Human Is Part of the Treatment Read More »








